Product name | Purity | Formulation |
Abamectin | 3% | ME |
Abamectin | 3% | EW |
Emamectin Benzoate | 3% | ME |
Abamectin·Lambda-cyhalothrin | 3%(0.2:2.8) | EC |
Buprofezin | 37% | SC |
Buprofezin | 75% | WP |
Emamectin Benzoate | 1% | ME |
Phoxim·Lambda-Cyhalothrin | 26%(1:25) | EC |
Bisultap | 29% | AS |
Monosultap | 90% | SP |
Imidacloprid·Monosultap | 30%(1:29) | WP |
Abamectin | 18g/L | EC |
Bifenthrin | 2.5% | EW |
Spinosad | 3% | EW |
Lambda-cyhalothrin | 5% | EW |
Abamectin·Chlopyrifos | 15%(0.2:14.8) | EW |
Abamectin·Triazophos | 20%(0.5:19.5) | EW |
Emamectin Benzoate·Triazophos | 20%(0.2:19.8) | ME |
Nitenpyram | 10% | AS |
Lambda-cyhalothrin | 5% | EW |
Fosthiazate·Chlopyrifos | 30%(15:15) | EC |
Abamectin | 1.8% | EW |
Buprofezin·Isoprocarb | 50%(12:38) | WP |
Buprofezin | 75% | WP |
Imidacloprid·Isoprocarb | 45%(5:40) | WP |
Abamectin·Buprofezin | 15%(0.15:14.85) | WP |
Chlopyrifos | 30% | EW |
Emamectin Benzoate | 3% | ME |
Methomyl | 20% | EC |
DDVP | 77.5% | EC |
Lambda Cypermethrin | 4.5% | EC |
Cypermethrin·Chlopyrifos | 25%(2.5:22.5) | EC |
Abamectin·Phoxim | 15%(0.1:14.9) | EC |
Abamectin | 1.8% | WP |
Methomyl·Chlopyrifos | 30%(10:20) | EC |
Fenvalerate·Malathion | 20%(5:15) | EC |
Abamectin | 1.8% | EC |
Acetamiprid | 3% | WP |
Bacillus thuringiensis | 16000IU/mg | WP |
Fenvalerate | 20% | EC |
Bifenthrin | 2.5% | EW |
Emamectin Benzoate·Chlorfenapyr | 6%(1:5) | ME |
Emamectin Benzoate·Hexaflumuron | 3%(1:2) | SC |
Nitenpyram·Buprofezin | 15%(5:10) | WP |
Flusilazole | 15% | EW |
Carbosulfan·Chlopyrifos | 5%(1:4) | GR |
Pymetrozine | 50% | WP |
Emamectin Benzoate | 5% | WDG |
Chlorfenapyr | 10% | ME |
Polyformaldehyde·Carbaryl | 6%(4.5:1.5) | GR |
Chlorfenapyr | 10% | SC |
Abamectin·Pyridaben | 10%(0.2:9.8) | EW |
Carbosulfan | 5% | GR |
Lambda Cyhalothrin | 10% | SC |
Acetamiprid | 20% | SL |
Chlopyrifos | 0.5% | GR |
Abamectin·Propargite | 40%(0.3:39.7) | EW |
Propargite | 30% | EW |
Padan | 0.8% | GR |
Acetamiprid | 40% | WDG |
Abamectin·Azocyclotin | 12.5%(0.5:12.25) | WP |
Propargite | 73% | EC |
Buprofezin·Chlopyrifos | 30%(15:15) | EC |
Emamectin Benzoate | 2% | ME |
Cypermethrin | 10% | EC |
344 Records Previous Next First 23456 |
product name | Purity | Formulation |
Fosthiazate | 20% | EW |
Kresoxim-methyl | 50% | WP |
Hymexazol | 0.1% | GR |
Hexaconazole | 5% | ME |
Carbendazim | 40%(20:20) | WP |
Triadimefon | 25% | WP |
Difenoconazole | 10% | WDG |
cymoxanil·Mancozeb | 72%(8:64) | WP |
Propamocarb·Sodium Cinnamate | 16.8%(1.8:15) | AS |
Sodium Cinnamate·Moroxydine | 5.9%(0.9:5) | AS |
Cupic Acetate Monohydrate | 20% | WDG |
Moroxydine Hydrochloride | 20%(10:10) | WP |
Mancozeb·Chlorothalonil | 64%(56:8) | WP |
Carbendazim | 25% | WP |
Pyrimethanil | 40% | SC |
Product name | Purity | Formulation |
Fosthiazate | 20% | EW |
Kresoxim-methyl | 50% | WP |
Hymexazol | 0.1% | GR |
Hexaconazole | 5% | ME |
Carbendazim | 40%(20:20) | WP |
Triadimefon | 25% | WP |
Difenoconazole | 10% | WDG |
cymoxanil·Mancozeb | 72%(8:64) | WP |
Propamocarb·Sodium Cinnamate | 16.8%(1.8:15) | AS |
Sodium Cinnamate·Moroxydine | 5.9%(0.9:5) | AS |
Cupic Acetate Monohydrate | 20% | WDG |
Moroxydine Hydrochloride | 20%(10:10) | WP |
Mancozeb·Chlorothalonil | 64%(56:8) | WP |
Carbendazim | 25% | WP |
Pyrimethanil | 40% | SC |
Product name | Purity | Formulation |
Fosthiazate | 20% | EW |
Kresoxim-methyl | 50% | WP |
Hymexazol | 0.1% | GR |
Hexaconazole | 5% | ME |
Carbendazim | 40%(20:20) | WP |
Triadimefon | 25% | WP |
Difenoconazole | 10% | WDG |
cymoxanil·Mancozeb | 72%(8:64) | WP |
Propamocarb·Sodium Cinnamate | 16.8%(1.8:15) | AS |
Sodium Cinnamate·Moroxydine | 5.9%(0.9:5) | AS |
Cupic Acetate Monohydrate | 20% | WDG |
Moroxydine Hydrochloride | 20%(10:10) | WP |
Mancozeb·Chlorothalonil | 64%(56:8) | WP |
Carbendazim | 25% | WP |
Pyrimethanil | 40% | SC |
Copyright(C)2017, Shandong Trustco Agrochem Co.,Ltd. All Rights Reserved.
Supported by ChemNet ChinaChemNet Toocle Copyright Notice Admin
鲁ICP备17025992号-1